Deutsche Bank Ag\ Genocea Biosciences, Inc. Transaction History

Deutsche Bank Ag\

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 14, 2020	SELL	$1.26 - $2.73 $13,008 - $28,184	-10,324 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.05 - $2.82 $21,164 - $29,113	10,324 New	10,324 $21,000

10K

Ticker GNCA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,783,500
Description
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.